GELITA launches Endotoxin Controlled Excipients for bioscience applications
New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting GELITA, a leading manufacturer of collagen and gelatin, proudly announces the launch of its Endotoxin Controlled Excipients (ECE) portfolio.[1] This cutting-edge product line, featuring VACCIPRO® and MEDELLAPRO®, meets the stringent demands of modern biomedical and pharmaceutical applications, including vaccine stabilization, medical devices, and 3D bioprinting. In pharmaceutical, medical […]
Key steps to bring ADCs successfully to clinical trial
The use of antibody-drug-conjugates (ADC) in drug development is becoming more and more widespread, thanks to their potential to improve the effectiveness of cancer treatments by enabling more precise targeting of cancerogenic cells. ADCs harness a mechanism based on an antigen-mediated uptake of a cytotoxic drug, which is then released directly into target cancer cells […]
Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)
Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The USFDA’s Office of Orphan Drug Products grants orphan status to support development of medicines for the treatment of rare diseases that […]
Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris
Live from Porte De Versailles, Paris: Pharmapack Europe 2025 (January 22–23) selects six start-ups from its 26 strong field of innovators to receive the Pharmapack Europe ‘heart of pharma’. A special commendation given to these early-stage companies advancing new breakthrough technologies. To highlight the depth of innovation across the event, six start-ups were selected regionally with […]
Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery
Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock™ Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product for US START-UP INITIATION WINNER Active Label for non-electric smart labels WOMAN OF THE YEAR Asmita […]
Zerion Pharma and Aché collaborate to exploit the Dispersome® technology for the improvement of two marketed drug products
Zerion Pharma< A/S (“ZERION”) today announces a partnership with Aché Laboratorios Farmacêuticos S.A. (“ACHÉ”), a major Brazilian pharmaceutical company. The partnership is aimed at taking advantage of ZERION’s expertise and its Dispersome® technology for improving the formulation of two drug products in the oncology and neuroscience areas that are currently marketed across the world, each with revenue in the […]
DFE Pharma appoints Sven Abend as new CEO
Goch, Germany – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced today that Dr. Sven Abend has been appointed as the new Chief Executive Officer (CEO). With 25 years of global business leadership experience, Abend will succeed Martti Hedman and assume his responsibilities on February 1st. Hedman has decided to retire from his position as CEO after three impactful years with DFE Pharma in which time he […]
At Pharmapack Europe, Schreiner MediPharm to Present Innovative Cap-Lock Label for Prefilled Syringes
Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, will present an innovative solution for the secure, blister-free packaging of syringes at Pharmapack Europe, January 22-23 in Paris. Together with partnering companies SCHOTT Pharma and Körber Pharma, Schreiner MediPharm (Booth C70) will demonstrate how sustainable packaging design […]
Aragen secures $100 Mn investment from Quadria Capital
Hyderabad, India and Singapore: Aragen, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has secured a $100 Mn investment from Quadria Capital, an Asia healthcare-focused Private Equity fund. The investment will result in Quadria acquiring a minority stake in Aragen, at an approximate valuation of USD 1.4 bn, primarily through a fresh capital infusion, with a small portion from the sale of shares by […]
Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0
Paris: Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A—alongside enhanced supply chain resilience as “The Good”. The ongoing uncertainty around the intentions and practical implications of the BIOSECURE ACT is “The Bad”, with Donald Trump’s presidential return once again “the Great Known Unknown”. The predictions come ahead […]
